skip to main content

H.R. 6009: Pandemic Cessation Act


The text of the bill below is as of Nov 17, 2021 (Introduced).


I

117th CONGRESS

1st Session

H. R. 6009

IN THE HOUSE OF REPRESENTATIVES

November 17, 2021

(for himself, Mr. Fallon, and Mr. Gohmert) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To provide that the public health emergency declared with respect to COVID–19 shall terminate on the date on which the Secretary of Health and Human Services approves, or authorizes emergency use of, a drug intended to treat COVID–19.

1.

Short title

This Act may be cited as the Pandemic Cessation Act.

2.

Termination of COVID–19 public health emergency

(a)

In general

The public health emergency declared pursuant to section 319 of the Public Health Service Act (42 U.S.C. 247d) on January 31, 2020, with respect to COVID–19, and any renewal thereof, shall terminate on the first date after the date of enactment of this Act on which the Secretary of Health and Human Services—

(1)

grants approval under section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) to an application with respect to a new drug intended to treat COVID–19; or

(2)

authorizes emergency use under section 564 of such Act (21 U.S.C. 360bbb–3) with respect to a drug intended to treat COVID–19.

(b)

Definition

In this section, the terms drug and new drug have the meanings given such terms in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321).